{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:01:45Z","timestamp":1790071305515,"version":"4.0.1"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":730,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:sec><jats:title\/><jats:p>Vitamin D is a secosteroid with known effects on calcium homeostasis that has recently been shown to have other significant functions regarding immune modulation, cell differentiation and proliferation, and the inflammatory response. As our understanding of the many functions of vitamin D has grown, the presence of vitamin D deficiency (VDD) has become more evident in Western populations. Concomitantly, nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease. NAFLD and VDD are often found together, and while this is not unexpected, given their similar associations with obesity and sedentary lifestyle, a growing body of evidence points to a closely linked and potentially causative relationship between VDD and NAFLD. The epidemiologic association between VDD and NAFLD as well as the role of VDD in the pathogenesis of NAFLD and the available evidence on the clinical utility of vitamin D replacement in NAFLD populations are discussed. (Hepatology 2013;53:1166\u20131174)<\/jats:p><\/jats:sec>","DOI":"10.1002\/hep.26390","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T09:34:18Z","timestamp":1363426458000},"page":"1166-1174","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":140,"title":["Vitamin D And Nonalcoholic Fatty Liver Disease (Nafld): Is It More Than Just An Association?"],"prefix":"10.1097","volume":"58","author":[{"given":"Ryan M.","family":"Kwok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-37-20241201","first-page":"531541","article-title":"Regulation of vitamin D metabolism.","volume":"25","author":"Henry","year":"2001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R2-37-20241201","first-page":"20322037","article-title":"Activation of vitamin D by the liver.","volume":"48","author":"Ponchon","year":"1969","journal-title":"J Clin Invest"},{"key":"R3-37-20241201","doi-asserted-by":"crossref","first-page":"561568","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"R4-37-20241201","doi-asserted-by":"crossref","first-page":"243253","DOI":"10.1016\/j.ecl.2010.02.002","article-title":"Vitamin D: metabolism.","volume":"39","author":"Christakos","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R5-37-20241201","doi-asserted-by":"crossref","first-page":"799802","DOI":"10.1016\/j.jsbmb.2006.12.053","article-title":"A genomewide linkage scan for 25OHD(3) and 1,25(0H)2D3 serum levels in asthma families.","volume":"103","author":"Wjst","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R6-37-20241201","doi-asserted-by":"crossref","first-page":"32733281","DOI":"10.1210\/jc.2008-1532","article-title":"Heritability and environmental factors affecting vitamin D status in rural Chinese adolescent twins.","volume":"94","author":"Arguelles","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-37-20241201","doi-asserted-by":"crossref","first-page":"549556","DOI":"10.1007\/s00439-010-0881-9","article-title":"Comprehensive association analysis of nine candidate genes with serum 25hydroxy vitamin D levels among healthy Caucasian subjects.","volume":"128","author":"Bu","year":"2010","journal-title":"Hum Genet"},{"key":"R8-37-20241201","first-page":"631636","article-title":"CYP2R1 (vitamin D 25hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans.","volume":"23","author":"RamosLopez","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"R9-37-20241201","first-page":"295302","article-title":"Vitamin D and the vitamin D receptor in liver pathophysiology.","volume":"35","author":"Zuniga","year":"2011","journal-title":"Clin Res Hep Gastro"},{"key":"R10-37-20241201","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1210\/jc.2008-1454","article-title":"Nonclassic actions of vitamin D.","volume":"94","author":"Bikle","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-37-20241201","first-page":"93101","article-title":"Immunoregulation by 1,25dihydroxyvitamin D3: basic concepts.","volume":"97","author":"Van Etten","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R12-37-20241201","first-page":"139146","article-title":"Identification and immune regulation of 25hydroxyvitamin D1alphahydroxylase in murine macrophages.","volume":"120","author":"Overbergh","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"R13-37-20241201","doi-asserted-by":"crossref","first-page":"17701773","DOI":"10.1126\/science.1123933","article-title":"Tolllike receptor triggering of a vitamin D mediated human antimicrobial response.","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"R14-37-20241201","doi-asserted-by":"crossref","first-page":"16341647","DOI":"10.4049\/jimmunol.179.3.1634","article-title":"Modulatory effects of 1,25 dihdroxyvitamin D3 on human B cell differentiation.","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"R15-37-20241201","doi-asserted-by":"crossref","first-page":"14511455","DOI":"10.1172\/JCI111557","article-title":"Inhibition of T lymphocyte mitogenesis by 1,25dihydroxyvitamin D3 (calcitriol).","volume":"74","author":"Rigby","year":"1984","journal-title":"J Clin Invest"},{"key":"R16-37-20241201","doi-asserted-by":"crossref","first-page":"49744980","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1a,25dihydroxyvitamin D3 has a direct effect on naive CD4()T cells to enhance the development of Th2 cells.","volume":"167","author":"Boonstra","year":"2001","journal-title":"J Immunol"},{"key":"R17-37-20241201","doi-asserted-by":"crossref","first-page":"1704S1708S","DOI":"10.1093\/jn\/125.suppl_6.1704S","article-title":"Immunosuppressive actions of 1,25dihydroxyvitamin D3: preferential inhibition of Th1 functions.","volume":"125","author":"Lemire","year":"1995","journal-title":"J Nutr"},{"key":"R18-37-20241201","doi-asserted-by":"crossref","first-page":"243246","DOI":"10.1016\/j.jsbmb.2010.03.001","article-title":"Regulatory T cell function correlates with serum 25hydroxyvitamin D, but not with 1,25 dihydroxyvitamin D, parathyroid hormone, and calcium levels in patients with relapsing remitting multiple sclerosis.","volume":"121","author":"Smolders","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R19-37-20241201","doi-asserted-by":"crossref","first-page":"344349","DOI":"10.1038\/ni.1851","article-title":"Vitamin D controls T cell antigen receptor signaling and activation of human T cells.","volume":"11","author":"Von Essen","year":"2010","journal-title":"Nat Immunol"},{"key":"R20-37-20241201","first-page":"147150","article-title":"The plasma insulin and growth hormone response to oral glucose: diurnal and seasonal observations in the Antarctic.","volume":"11","author":"Campbell","year":"1975","journal-title":"Diabetologia"},{"key":"R21-37-20241201","doi-asserted-by":"crossref","first-page":"10051015","DOI":"10.1038\/ejcn.2011.118","article-title":"Vitamin D and type 2 diabetes: a systematic review.","volume":"65","author":"Mitri","year":"2011","journal-title":"Eur J Clin Nut"},{"key":"R22-37-20241201","doi-asserted-by":"crossref","first-page":"509511","DOI":"10.1096\/fj.02-0424fje","article-title":"Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor.","volume":"17","author":"Zeitz","year":"2003","journal-title":"FASEB J"},{"key":"R23-37-20241201","first-page":"121125","article-title":"Expression of 25hydroxyvitamin D31alphahydroxylase in pancreatic islets.","volume":"8990","author":"Bland","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R24-37-20241201","doi-asserted-by":"crossref","first-page":"223230","DOI":"10.1016\/S0960-0760(03)00032-3","article-title":"Identification of vitamin D response element in the human insulin receptor gene promoter.","volume":"84","author":"Maestro","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R25-37-20241201","doi-asserted-by":"crossref","first-page":"227232","DOI":"10.1002\/cbf.951","article-title":"Transcriptional activation of the human insulin receptor gene by 1,25dihydroxyvitamin D(3).","volume":"20","author":"Maestro","year":"2002","journal-title":"Cell Biochem Funct"},{"key":"R26-37-20241201","first-page":"16","article-title":"Hypovitamosis D associations with adverse metabolic parameters are accentuated in patients with diabetes mellitus type 2: a BMIindependent role of adiponectin.","volume":"36","author":"AlDaghri","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"R27-37-20241201","doi-asserted-by":"crossref","first-page":"229238","DOI":"10.1172\/JCI0215219","article-title":"1,25Dihydroxyvitamin D(3) is a negative endocrine regulator of the reninangiotensin system.","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"R28-37-20241201","doi-asserted-by":"crossref","first-page":"807825","DOI":"10.1016\/S1357-2725(02)00311-4","article-title":"The adiposetissue reninangiotensin aldosterone system: role in the metabolic syndrome?","volume":"35","author":"Engeli","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"R31-37-20241201","doi-asserted-by":"crossref","first-page":"15861591","DOI":"10.1093\/ajcn\/85.6.1586","article-title":"Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.","volume":"85","author":"Lappe","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"R32-37-20241201","doi-asserted-by":"crossref","first-page":"235241","DOI":"10.1001\/jama.2010.518","article-title":"Prevalence and trends in obesity among US adults, 19992008.","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"},{"key":"R33-37-20241201","doi-asserted-by":"crossref","first-page":"113121","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population based cohort study.","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"R34-37-20241201","doi-asserted-by":"crossref","first-page":"21242129","DOI":"10.1007\/s10620-011-1707-x","article-title":"Serum vitamin D concentrations and unexplained elevation in ALT among US adults.","volume":"56","author":"Liangpunsakul","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R35-37-20241201","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1741-7015-9-85","article-title":"Strong association between nonalcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes.","volume":"9","author":"Barchetta","year":"2011","journal-title":"BMC Med"},{"key":"R36-37-20241201","doi-asserted-by":"crossref","first-page":"517524","DOI":"10.1016\/j.numecd.2006.04.002","article-title":"Associations between serum 25hydroxyvitamin D3 concentrations and liver histology in patients with nonalcoholic fatty liver disease.","volume":"17","author":"Targher","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R37-37-20241201","doi-asserted-by":"crossref","first-page":"15191523","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights.","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"R38-37-20241201","doi-asserted-by":"crossref","first-page":"544563","DOI":"10.1016\/j.cld.2009.07.009","article-title":"Role of insulin resistance in lipotoxicity in nonalcoholic steatohepatitis.","volume":"13","author":"Cusi","year":"2009","journal-title":"Clin Liver Dis"},{"key":"R39-37-20241201","doi-asserted-by":"crossref","first-page":"527534","DOI":"10.1016\/j.jnutbio.2010.04.007","article-title":"Role of tumor necrosis factor alpha in the onset of fructoseinduced nonalcoholic fatty liver disease in mice.","volume":"22","author":"Kanuri","year":"2011","journal-title":"J Nutr Biochem"},{"key":"R40-37-20241201","doi-asserted-by":"crossref","first-page":"911919","DOI":"10.1016\/j.jaci.2005.02.023","article-title":"Adipose tissue, adipokines, and inflammation.","volume":"115","author":"Fantuzzi","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"R41-37-20241201","doi-asserted-by":"crossref","first-page":"18361846","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"R42-37-20241201","doi-asserted-by":"crossref","first-page":"769775","DOI":"10.1111\/j.1365-2036.2010.04405.x","article-title":"Pioglitazone in the treatment of NASH: the role of adiponectin.","volume":"32","author":"Gastaldelli","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R43-37-20241201","doi-asserted-by":"crossref","first-page":"234239","DOI":"10.1016\/j.tips.2009.02.004","article-title":"Adiponectin in health and disease: evaluation of adiponectintargeted drug development strategies.","volume":"30","author":"Shetty","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"R44-37-20241201","doi-asserted-by":"crossref","first-page":"91100","DOI":"10.1172\/JCI200317797","article-title":"The fatderived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"R45-37-20241201","doi-asserted-by":"crossref","first-page":"26212637","DOI":"10.1172\/JCI31021","article-title":"Obesityassociated improvements in metabolic profile through expansion of adipose tissue.","volume":"117","author":"Kim","year":"2007","journal-title":"J Clin Invest"},{"key":"R46-37-20241201","doi-asserted-by":"crossref","first-page":"934945","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: cytokineadipokine interplay and regulation of insulin resistance.","volume":"131","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"key":"R47-37-20241201","doi-asserted-by":"crossref","first-page":"186191","DOI":"10.1038\/oby.2011.210","article-title":"The independent association between 25hydroxyvitamin D and adiponectin and its relation with BMI in large cohorts: the NHS and the HPFS.","volume":"20","author":"Vaidya","year":"2012","journal-title":"Obesity"},{"key":"R48-37-20241201","first-page":"965971","article-title":"Vitamin D in relationship to metabolic risk factors, insulin sensitivity, and adiponectin in a young MiddleEastern population.","volume":"160","author":"GannageYared","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R49-37-20241201","doi-asserted-by":"crossref","first-page":"205210","DOI":"10.1007\/s12020-009-9216-9","article-title":"The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance.","volume":"36","author":"Nimitphong","year":"2009","journal-title":"Endocrine"},{"key":"R50-37-20241201","doi-asserted-by":"crossref","first-page":"85368541","DOI":"10.1073\/pnas.97.15.8536","article-title":"Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets.","volume":"97","author":"Kakuma","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R51-37-20241201","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1155\/2009\/831670","article-title":"Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis in therapy.","volume":"2009","author":"Tsochatzis","year":"2009","journal-title":"Mediators Inflamm"},{"key":"R52-37-20241201","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s10753-009-9155-x","article-title":"Resistin upregulates COX2 expression via TAK1IKKNFkappaB signaling pathways.","volume":"33","author":"Zhang","year":"2010","journal-title":"Inflammation"},{"key":"R53-37-20241201","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factoralpha: direct role in obesitylinked insulin resistance.","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"R54-37-20241201","doi-asserted-by":"crossref","first-page":"12591264","DOI":"10.1136\/gut.2010.214577","article-title":"Antiinflammatory effects of excessive weight loss: potent suppression of adipose interleukin6 and tumor necrosis factoralpha expression.","volume":"59","author":"Moschen","year":"2010","journal-title":"Gut"},{"key":"R55-37-20241201","doi-asserted-by":"crossref","first-page":"1374013746","DOI":"10.1074\/jbc.M210689200","article-title":"Suppressor of cytokine signaling (SOCS3), a potential mediator of interleukin6dependent insulin resistance in hepatocytes.","volume":"278","author":"Senn","year":"2003","journal-title":"J Biol Chem"},{"key":"R56-37-20241201","doi-asserted-by":"crossref","first-page":"343350","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.","volume":"37","author":"Li","year":"2003","journal-title":"Hepatology"},{"key":"R57-37-20241201","doi-asserted-by":"crossref","first-page":"11031111","DOI":"10.1002\/hep.24737","article-title":"Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Tolllike receptor activation.","volume":"55","author":"Roth","year":"2012","journal-title":"Hepatology"},{"key":"R58-37-20241201","doi-asserted-by":"crossref","first-page":"17611772","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance.","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"R59-37-20241201","doi-asserted-by":"crossref","first-page":"12191223","DOI":"10.1093\/ajcn\/87.5.1219","article-title":"Energy intake is associated with endotoxemia in apparently healthy men.","volume":"87","author":"Amar","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R60-37-20241201","doi-asserted-by":"crossref","first-page":"30153025","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acidinduced resistance.","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest"},{"key":"R61-37-20241201","doi-asserted-by":"crossref","first-page":"19861998","DOI":"10.2337\/db06-1595","article-title":"Lossoffunction mutation in tolllike receptor 4 prevents dietinduced obesity and insulin resistance.","volume":"56","author":"Tsukumo","year":"2007","journal-title":"Diabetes"},{"key":"R62-37-20241201","first-page":"228231","article-title":"Metabolic syndrome and altered gut microbiota in mice lacking Tolllike receptor 5.","volume":"328","author":"VijayKumar","year":"2010","journal-title":"Science"},{"key":"R63-37-20241201","first-page":"2847","article-title":"Role of Tolllike receptors and their downstream molecules in the development of nonalcoholic fatty liver disease.","volume":"366","author":"Miura","year":"2010","journal-title":"Gastroenterol Res Pract"},{"key":"R64-37-20241201","first-page":"1719","article-title":"FXR signaling in the enterohepatic system.","volume":"368","author":"Matsubara","year":"2013","journal-title":"Mol Clin Endocrinol"},{"key":"R65-37-20241201","doi-asserted-by":"crossref","first-page":"45775","DOI":"10.1002\/bdd.682","article-title":"1alpha,25dihydroxyvtaimin D(3) triggered vitamin D receptor and FXR receptorlike effects in rat intestine and liver in vivo.","volume":"30","author":"Chow","year":"2009","journal-title":"Biopharm Drug Dispos"},{"key":"R66-37-20241201","doi-asserted-by":"crossref","first-page":"837858","DOI":"10.1016\/j.cgh.2012.03.011","article-title":"Features, diagnosis, and treatment of nonalcoholic fatty liver disease.","volume":"10","author":"Torres","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R67-37-20241201","doi-asserted-by":"crossref","first-page":"17281737","DOI":"10.1136\/gut.2010.234666","article-title":"Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamindeinduced liver fibrosis in rats.","volume":"60","author":"Abramovitch","year":"2011","journal-title":"Gut"},{"key":"R68-37-20241201","doi-asserted-by":"crossref","first-page":"400407","DOI":"10.4318\/tjg.2011.0254","article-title":"Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate line LX2.","volume":"22","author":"Seydel","year":"2011","journal-title":"Turk J Gastroenterol"},{"key":"R69-37-20241201","doi-asserted-by":"crossref","first-page":"415425","DOI":"10.1016\/j.jhep.2010.11.028","article-title":"Impact of artificial sunlight on the progress of NAFLD in rats.","volume":"55","author":"Nakano","year":"2011","journal-title":"J Hepatol"},{"key":"R70-37-20241201","first-page":"10111019","article-title":"A randomized controlled trial of highdose UDCA for NASH.","volume":"54","author":"Ratziu","year":"2011","journal-title":"J Hepatol"},{"key":"R71-37-20241201","doi-asserted-by":"crossref","first-page":"252257","DOI":"10.1038\/sj.bjc.6601104","article-title":"A phase II study of the vitamin D analogue seocalcitol in patients with inoperable hepatocellular carcinoma.","volume":"89","author":"Dalhoff","year":"2003","journal-title":"Br J Cancer"},{"key":"R72-37-20241201","first-page":"805824","article-title":"Diseasespecific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis.","volume":"12","author":"Van der Poorten, George","year":"2008","journal-title":"Clin Liv Dis"},{"key":"R73-37-20241201","doi-asserted-by":"crossref","first-page":"248254","DOI":"10.1056\/NEJMcp1009570","article-title":"Vitamin D insufficiency.","volume":"364","author":"Rosen","year":"2011","journal-title":"N Engl J Med"},{"key":"R74-37-20241201","first-page":"681683","article-title":"Clinical inquiries. Which regimen treated vitamin D deficiency most effectively?","volume":"60","author":"Osborn","year":"2011","journal-title":"J Fam Pract"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26390","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201309000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:47:14Z","timestamp":1745974034000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201309000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26390","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}